Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A kindred with hemoglobin Lepore

R A O'Reilly

    JAMA
    |August 2, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Hemoglobin Lepore trait, a genetic blood disorder, was identified in a multi-generational family. This condition presents with mild anemia and specific red blood cell abnormalities, mimicking beta-thalassemia trait.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Minor differences in perceived sheepmeat eating quality scores of Australian, Chinese and American consumers.

    Meat science·2020
    Same author

    Factors affecting lamb eating quality and the potential for their integration into an MSA sheepmeat grading model.

    Meat science·2018
    Same author

    Impacts on rural livelihoods in Cambodia following adoption of best practice health and husbandry interventions by smallholder cattle farmers.

    Transboundary and emerging diseases·2014
    Same author

    Splenomegaly at a university hospital compared to a nearby county hospital in 317 patients.

    Acta haematologica·1999
    Same author

    Prospective evaluation of anticoagulant reversal with oral vitamin K1 while continuing warfarin therapy unchanged.

    Chest·1999
    Same author

    Splenomegaly in 2,505 patients in a large university medical center from 1913 to 1995. 1913 to 1962: 2,056 patients.

    The Western journal of medicine·1998
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    Same journal

    HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

    JAMA·2026
    Same journal

    US Dietary Supplement Use Increasing, Especially in Older Adults.

    JAMA·2026
    Same journal

    Heat Stress From Climate Change Surges Globally.

    JAMA·2026
    Same journal

    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

    JAMA·2026
    See all related articles

    Area of Science:

    • Hematology
    • Medical Genetics
    • Molecular Biology

    Background:

    • Hemoglobinopathies represent a significant global health burden.
    • Understanding genetic variations in hemoglobin is crucial for diagnosing blood disorders.
    • Beta-thalassemia trait is a common inherited blood disorder characterized by reduced beta-globin synthesis.

    Observation:

    • A family of Italian descent presented with mild anemia and microcytic, hypochromic red blood cells.
    • Hemoglobin analysis revealed an abnormal hemoglobin component (11-14%) migrating similarly to Hemoglobin S.
    • Amino acid sequencing confirmed the abnormal hemoglobin as Hemoglobin Lepore, a delta-beta fusion chain.

    Findings:

    • The identified abnormal hemoglobin was characterized as Hemoglobin Lepore, with a specific delta-beta fusion.

    Related Experiment Videos

  • The crossover point in the delta-beta fusion chain was localized between residues 87 and 116.
  • Affected individuals exhibited clinical and laboratory features consistent with beta-thalassemia trait.
  • Implications:

    • Hemoglobin Lepore trait diagnosis requires consideration in patients presenting with beta-thalassemia-like symptoms.
    • Accurate identification of Hemoglobin Lepore is essential for genetic counseling and management.
    • This finding expands the spectrum of hemoglobin variants that can mimic common hematological conditions.